In contrast, in CD4+ T cells TGF-β is known to decrease TCR activation29,64, restrict proliferation and inhibit cytotoxicity (including granzyme and perforin release) at different stage of infection in vivo30,65. This evidence concerns the gene TGFB1 and infection.